Ultrasound Needle Guides Market Size, Share, Future Analysis, 2026-2034

Market Overview

According to Fortune Business Insights, the global ultrasound needle guides market size was valued at USD 391.7 million in 2025. The market is projected to grow from USD 416.1 million in 2026 to USD 620.6 million by 2034, exhibiting a CAGR of 5.1% during the forecast period. North America dominated the ultrasound needle guides market with a market share of 32.78% in 2025.

Fortune Business Insights™ has deep-dived into these insights in its latest research report, titled “Ultrasound Needle Guides Market, 2026-2034.”

The analysis shows that the market growth is heavily influenced by an increasing shift toward minimally invasive and ultrasound-guided procedures, such as biopsies and fluid aspirations, which shorten procedure times, improve needle visualization, and reduce complications. For example, according to data from the National Center for Biotechnology Information (NCBI) in October 2025, a study at University Hospital Würzburg in Germany reported that out of 250 biopsies performed, 118 (47.2%) utilized ultrasound guidance. This trend indicates a strong demand for ultrasound needle guides worldwide.

Major Players Profiled in the Market Report:

• CIVCO Medical Solutions (U.S.)

• GE Healthcare (U.S.)

• FUJIFILM Sonosite, Inc. (U.S.)

• Sheathing Technologies, Inc. (U.S.)

• Aspen Surgical (U.S.)

• Argon Medical Devices (U.S.)

• GEOTEK (U.S.)

• Mermaid Medical (Denmark)

Segments

Elimination of Reprocessing and Reduced Cross-Contamination to Propel Disposable Segment GrowthBased on type, the market is divided into reusable and disposable. The disposable segment holds the largest market share and dominates the market owing to its significant comparative advantages, such as eliminating reprocessing steps, reducing cross-contamination risks, and simplifying logistics for interventional radiology suites and day-care centers. Meanwhile, the reusable segment is projected to grow at a CAGR of 4.5% during the forecast period.

Increasing Number of Prostate Biopsies to Drive Biopsy Segment ExpansionBy application, the market is categorized into biopsy, regional anesthesia, vascular access, nerve block, fluid aspiration, and others. The biopsy segment is leading the market—projected to account for a 31.6% market share in 2026—as there is a high demand driven by the shift from CT-guided to ultrasound-guided procedures and the rising number of prostate biopsies globally (with UCLA Health reporting nearly 1 million prostate biopsies performed annually in the U.S.). Additionally, the vascular access segment is projected to grow at a rapid CAGR of 5.4%.

Hospitals & ASCs to Dominate the Market Due to High Procedure Volumes and Reimbursement PartnershipsBased on end-user, the market is segmented into hospitals & ASCs, clinics, diagnostic imaging centers, and others. The hospitals & ASCs segment holds the largest market share (projected to hold 69.2% in 2026) owing to the higher volume of ultrasound-guided procedures performed in these settings, better care accessibility, and favorable partnerships with reimbursement providers. The clinics segment is projected to grow at a CAGR of 5.1% during the forecast period.

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

For detailed market insights: https://www.fortunebusinessinsights.com/ultrasound-needle-guides-market-115033

Report CoverageThe report offers:

• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.

• Comprehensive insights into regional developments.

• List of major industry players.

• Key strategies adopted by the market players.

• The latest industry developments include product launches, partnerships, mergers, and acquisitions.

Drivers & Restraints

Rising Volume of Ultrasound-Guided Minimally Invasive Procedures to Propel Market GrowthThe surge in replacing traditional landmark-based techniques with ultrasound guidance across procedures such as liver and prostate biopsies, central line placements, and regional anesthesia is boosting the ultrasound needle guides market growth. Through this technology, even less experienced clinicians can perform procedures with high accuracy and precision, accelerating global device adoption.

However, price sensitivity, capital budget constraints, and workforce training gaps may hamper market growth. Needle guides are often treated as low-margin accessories bundled with probes, and hospitals in middle- and low-income countries frequently favor cheaper reusable guides over premium disposables. Additionally, high price competition among similar probe-compatible guides, supply-chain complexities, and a looming shortage of healthcare professionals (exceeding 3.0 million in the U.S. alone) may limit procedure volumes and market expansion.

Regional Insights

Favorable Reimbursement and Expanding ASC Infrastructure in the U.S. Propels Market Growth in North AmericaNorth America holds the dominant ultrasound needle guides market share (valued at USD 128.4 million in 2025) and is projected to experience steady growth during the forecast period, with the U.S. market estimated to reach USD 126.9 million in 2026. The region’s growth is attributed to favorable reimbursement policies for ultrasound-guided interventions and the increasing number of hospitals and Medicare-certified Ambulatory Surgical Centers (which grew by 2.5% to 6,308 facilities from 2022 to 2023).

Europe and Asia Pacific are also witnessing notable expansion in the market. Europe is projected to grow at a CAGR of 5.0% (the second-highest globally) to reach USD 123.2 million by 2026, driven by a large prostate cancer patient pool in countries like Germany, France, and the U.K. Meanwhile, Asia Pacific is set to emerge as the third-largest market (reaching USD 120.1 million in 2026), fueled by rapidly expanding hospital and diagnostic imaging infrastructure in developing nations such as China and India.

Ultrasound Needle Guides Market Future Growth:The ultrasound needle guides market is experiencing robust growth, fueled by a strong shift toward sterile disposable solutions, rising adoption of transperineal prostate biopsies, and the integration of AI and sensor-enabled tracking technologies. Today's healthcare providers are increasingly drawn to sterile disposables in oncology and IVF to prevent cross-contamination, as well as specialized transperineal guides that lower sepsis rates in urology. Additionally, there is growing interest in deep learning-based needle tracking systems—which embed sensors to verify real-time needle position and overcome poor visibility in conventional 2D ultrasound—alongside eco-friendly disposable materials and guides optimized for handheld and micro-ultrasound scanners. While North America and Europe continue to dominate procedure volumes, the Asia-Pacific region is seeing a surge in demand driven by healthcare infrastructure modernization.

Competitive Landscape

Growing Focus on Product Diversification and Technological Innovation to Propel Market GrowthThe market features prominent players like CIVCO Medical Solutions, GE Healthcare, FUJIFILM Sonosite, Inc., and others. These leading companies are accelerating growth through strategic initiatives such as continuous technological innovation, product portfolio diversification, commercialization of sensor-enabled and transperineal guides, partnerships with healthcare facilities, and geographical expansion. Their proactive approach to enhancing procedural precision and compatibility across a wide range of ultrasound probes continues to fuel the market’s momentum.

Key Industry Development

• October 2025: Rivanna Medical, Inc. was awarded a USD 3.0 million Congressionally Directed Medical Research Program (CDMRP) grant to develop a military-optimized ultrasound guidance system for spinal interventions.

• September 2025: Rivanna Medical, Inc. received a USD 2.21 million Small Business Innovation Research (SBIR) Direct to Phase II grant from the National Cancer Institute (NCI) at the NIH to develop an ultrasound guidance system for pediatric lumbar punctures using its Accuro 3S platform.

• September 2024: Rivanna Medical, Inc. secured US Patent #11,432,801 B2 for an advanced ultrasound-guided needle insertion system featuring a dual-array probe for enhanced visibility and precision.

• November 2023: DeepSight Technology introduced NeedleVue, an ultrasound-guided needle technology using proprietary sensors to provide real-time verification of tool position and enhance safety.

• April 2023: BD launched the Prevue II System, an advanced ultrasound device with real-time needle depth markers and BD Cue Needle Tracking to enhance first-stick success in IV insertions.

• March 2021: ECIO LEAPMED launched the X-Needle Guide Disposable Guide V3.0, emphasizing high precision and ease of use in interventional procedures.

Explore Japan’s Market Opportunities - Latest Ultrasound Needle Guides Market Insights